INSP•businesswire•
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
Summary
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOS
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 14, 2025 by businesswire